ANIK Q1 2018 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M-9.1% YoY

Gross Profit

$13M63.1% margin

Operating Income

-$8M-36.8% margin

Net Income

-$7M-31.4% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

-27.6%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$7M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$284M

Total Liabilities

$21M

Stockholders' Equity

$264M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$23M	-9.1%
Gross Profit	$13M	$17M	-22.4%
Operating Income	-$8M	$8M	-197.8%
Net Income	-$7M	$5M	-221.7%

Revenue Segments

Product

$21M49%

Orthobiologics

$19M45%

Surgical

$1M3%

Manufactured Product, Other

$1M2%

Geographic Segments

UNITED STATES

$17M88%

Europe

$2M12%